You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
CRA International, Inc. reported 12% revenue growth in the first two quarters of 2026 and 9% in fiscal 2025, expects durable rate increases into 2027, and targets mid single digits headcount growth while maintaining high 70s utilization.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. CRA reported record Q2 revenue of $210.8 million (up 12.8% year-over-year) with broad-based practice and geographic growth, raised full-year 2026 revenue guidance to $805M–$820M from $785M–$805M, and reaffirmed its 12.0%–13.0% EBITDA margin outlook.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Billed and unbilled receivables | 271.7M | as of July 4, 2026 | — |
| Client reimbursables | $20.1M | Q2 fiscal 2026 | — |
| Consultant headcount | 968 | Q2 fiscal 2026 | — |
| DSO - billed | 68 | Q2 FY2026 | — |
| DSO - unbilled | 45 | Q2 FY2026 | — |
| Non-GAAP EBITDA non-GAAP | $26.8M | second quarter of fiscal 2026 | — |
| Non-GAAP EBITDA margin non-GAAP | 12.7% | second quarter of fiscal 2026 | — |
| Revenues derived from fixed-price projects | 23% | the second quarter of fiscal 2026 filing | — |
| Revenues outside of the U.S. | 22% | the second quarter of fiscal 2026 filing | — |
| Revolving credit facility borrowing capacity | $77.3M | Q2 fiscal 2026 | — |
| Total Days Sales Outstanding | 113 | Q2 FY2026 | — |
| Utilization | 77% | second quarter of fiscal 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CRAI
this stock
Cra International, Inc.
|
$1.27B | +1.1% | +9.3% | 24.6 | 5.2% |
|
VRSK
Verisk Analytics, Inc.
|
$27.13B | -5.5% | +6.6% | 32.1 | 3.4% |
|
EFX
Equifax Inc
|
$22.68B | -10.7% | +6.9% | 31.3 | 4.8% |
|
BAH
Booz Allen Hamilton Holding Corp
|
$10.59B | +5.9% | -6.4% | 13.9 | 5.6% |
|
FCN
Fti Consulting, Inc
|
$5.34B | +14.7% | +2.4% | 24.5 | 11.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CRAI | +3.1% | +14.3% | +47.3% | +3.5% | +1.1% |
| SPY | -4.7% | -5.3% | -0.8% | -3.0% | +7.5% |
| vs SPY | +7.9% | +19.6% | +48.2% | +6.5% | -6.4% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
